439 related articles for article (PubMed ID: 24621122)
1. Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.
Akuffo KO; Beatty S; Stack J; Dennison J; O'Regan S; Meagher KA; Peto T; Nolan J
Ophthalmic Epidemiol; 2014 Apr; 21(2):111-23. PubMed ID: 24621122
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
[TBL] [Abstract][Full Text] [Related]
3. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
4. Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: Central Retinal Enrichment Supplementation Trials - Report 1.
Nolan JM; Power R; Stringham J; Dennison J; Stack J; Kelly D; Moran R; Akuffo KO; Corcoran L; Beatty S
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3429-39. PubMed ID: 27367585
[TBL] [Abstract][Full Text] [Related]
5. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Stringham JM; Stringham NT
Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial.
Akuffo KO; Beatty S; Peto T; Stack J; Stringham J; Kelly D; Leung I; Corcoran L; Nolan JM
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5347-5360. PubMed ID: 29053808
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
[TBL] [Abstract][Full Text] [Related]
8. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.
Nolan JM; Akkali MC; Loughman J; Howard AN; Beatty S
Exp Eye Res; 2012 Aug; 101():9-15. PubMed ID: 22652506
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
10. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J
Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657
[TBL] [Abstract][Full Text] [Related]
11. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.
Piermarocchi S; Saviano S; Parisi V; Tedeschi M; Panozzo G; Scarpa G; Boschi G; Lo Giudice G;
Eur J Ophthalmol; 2012; 22(2):216-25. PubMed ID: 22009916
[TBL] [Abstract][Full Text] [Related]
12. Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration.
Akuffo KO; Nolan JM; Howard AN; Moran R; Stack J; Klein R; Klein BE; Meuer SM; Sabour-Pickett S; Thurnham DI; Beatty S
Eye (Lond); 2015 Jul; 29(7):902-12. PubMed ID: 25976647
[TBL] [Abstract][Full Text] [Related]
13. Supplementation with all three macular carotenoids: response, stability, and safety.
Connolly EE; Beatty S; Loughman J; Howard AN; Louw MS; Nolan JM
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9207-17. PubMed ID: 21979997
[TBL] [Abstract][Full Text] [Related]
14. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
15. The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial.
Nolan JM; Loskutova E; Howard A; Mulcahy R; Moran R; Stack J; Bolger M; Coen RF; Dennison J; Akuffo KO; Owens N; Power R; Thurnham D; Beatty S
J Alzheimers Dis; 2015; 44(4):1157-69. PubMed ID: 25408222
[TBL] [Abstract][Full Text] [Related]
16. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
Sabour-Pickett S; Beatty S; Connolly E; Loughman J; Stack J; Howard A; Klein R; Klein BE; Meuer SM; Myers CE; Akuffo KO; Nolan JM
Retina; 2014 Sep; 34(9):1757-66. PubMed ID: 24887490
[TBL] [Abstract][Full Text] [Related]
17. Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Power R; Coen RF; Beatty S; Mulcahy R; Moran R; Stack J; Howard AN; Nolan JM
J Alzheimers Dis; 2018; 61(3):947-961. PubMed ID: 29332050
[TBL] [Abstract][Full Text] [Related]
18. Macular pigment and its contribution to vision.
Loskutova E; Nolan J; Howard A; Beatty S
Nutrients; 2013 May; 5(6):1962-9. PubMed ID: 23760061
[TBL] [Abstract][Full Text] [Related]
19. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
20. Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
Thurnham DI; Nolan JM; Howard AN; Beatty S
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1231-43. PubMed ID: 25311651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
